Hiroaki Miyoshi

4.7k total citations · 1 hit paper
166 papers, 2.6k citations indexed

About

Hiroaki Miyoshi is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Hiroaki Miyoshi has authored 166 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Pathology and Forensic Medicine, 69 papers in Oncology and 55 papers in Immunology. Recurrent topics in Hiroaki Miyoshi's work include Lymphoma Diagnosis and Treatment (76 papers), Viral-associated cancers and disorders (39 papers) and T-cell and Retrovirus Studies (34 papers). Hiroaki Miyoshi is often cited by papers focused on Lymphoma Diagnosis and Treatment (76 papers), Viral-associated cancers and disorders (39 papers) and T-cell and Retrovirus Studies (34 papers). Hiroaki Miyoshi collaborates with scholars based in Japan, United States and China. Hiroaki Miyoshi's co-authors include Koichi Ohshima, Fumiko Arakawa, Junichi Kiyasu, Daisuke Niino, Yasuo Sugita, Ayako Ichikawa, Keisuke Kawamoto, Noriaki Yoshida, Shintaro Yokoyama and Kensaku Sato and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Hiroaki Miyoshi

148 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma

2015 367 citations Junichi Kiyasu, Hiroaki Miyoshi et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroaki Miyoshi Japan	24	1.3k	1.2k	755	509	380	166	2.6k
Richard Delarue France	25	734 0.6×	947 0.8×	333 0.4×	475 0.9×	381 1.0×	91	2.1k
Joo Y. Song United States	21	944 0.7×	947 0.8×	359 0.5×	342 0.7×	246 0.6×	131	1.8k
Konnie M. Hebeda Netherlands	27	883 0.7×	1.3k 1.0×	362 0.5×	457 0.9×	155 0.4×	93	2.5k
Christine Beham‐Schmid Austria	30	640 0.5×	754 0.6×	386 0.5×	555 1.1×	165 0.4×	126	2.5k
Bruno Chetaille France	24	839 0.7×	551 0.4×	669 0.9×	224 0.4×	153 0.4×	62	2.2k
Michael Bishop United States	24	1.1k 0.8×	666 0.5×	345 0.5×	354 0.7×	166 0.4×	119	2.8k
David Wu United States	21	1.1k 0.9×	556 0.4×	631 0.8×	289 0.6×	102 0.3×	65	2.4k
Korinna Jöhrens Germany	31	1.4k 1.1×	484 0.4×	748 1.0×	213 0.4×	107 0.3×	138	3.2k
Paul T. Finger United States	49	2.2k 1.7×	554 0.4×	379 0.5×	364 0.7×	560 1.5×	264	7.4k
Meora Feinmesser Israel	31	766 0.6×	725 0.6×	279 0.4×	239 0.5×	170 0.4×	121	2.6k

Countries citing papers authored by Hiroaki Miyoshi

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Miyoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Miyoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Miyoshi more than expected).

Fields of papers citing papers by Hiroaki Miyoshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Miyoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Miyoshi. The network helps show where Hiroaki Miyoshi may publish in the future.

Co-authorship network of co-authors of Hiroaki Miyoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Miyoshi. A scholar is included among the top collaborators of Hiroaki Miyoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Miyoshi. Hiroaki Miyoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kato, Seiichi, Motoharu Hamada, Akinao Okamoto, et al.. (2024). EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome. Blood Advances. 8(9). 2138–2147. 9 indexed citations

Furuta, Takuya, Hiroaki Miyoshi, Hideo Nakamura, et al.. (2023). Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas. Journal of Neuro-Oncology. 164(3). 633–641. 5 indexed citations

Yasunaga, Jun‐ichirou, Yuichiro Arima, Kenichi Tsujita, et al.. (2023). HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion. Blood Cancer Discovery. 4(5). 374–393. 9 indexed citations

Tanaka, Ken, Hiroaki Miyoshi, Keisuke Kawamoto, et al.. (2023). Clinicopathological analysis of CD47 and signal regulatory protein alpha expression in myeloid sarcoma patients: CD47 expression is a favourable prognostic factor. Pathology. 56(1). 81–91. 2 indexed citations

Tanaka, Yasuhiro, et al.. (2022). Intestinal T-Cell Lymphoma With Lung and Lymph Node Involvement at Relapse. Journal of Medical Cases. 13(1). 15–20.

Fujiwara, Takeshi, Hiroaki Miyoshi, Norifumi L. Yamada, et al.. (2022). Neutron flat-panel detector using In–Ga–Zn–O thin-film transistor. Review of Scientific Instruments. 93(1). 13304–13304. 8 indexed citations

Miyoshi, Hiroaki, Keisuke Kawamoto, Mai Takeuchi, et al.. (2021). Clinicopathological analysis of myeloid sarcoma with megakaryocytic differentiation. Pathology. 54(4). 442–448. 6 indexed citations

Arakawa, Fumiko, Hiroaki Miyoshi, Noriaki Yoshida, et al.. (2021). Expression of telomerase reverse transcriptase in peripheral T‐cell lymphoma. Cancer Medicine. 10(19). 6786–6794. 4 indexed citations

Hashizume, Naoki, Suguru Fukahori, Yoshinori Koga, et al.. (2020). Benign mesenteric lipomatous tumor in a child: a case report and literature review. SHILAP Revista de lepidopterología. 6(1). 243–243. 11 indexed citations

10.

Tanaka, Yasuhiro, et al.. (2019). Spontaneous regression of diffuse large B-cell lymphoma in the small intestine with multiple lymphadenopathy. Journal of Clinical and Experimental Hematopathology. 59(1). 17–21. 7 indexed citations

11.

Furuta, Takuya, Hiroaki Miyoshi, Satoru Komaki, et al.. (2018). Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma. Neuropathology. 38(3). 218–227. 29 indexed citations

12.

Kawamoto, Keisuke, Hiroaki Miyoshi, Takaharu Suzuki, et al.. (2018). Expression of programmed death ligand 1 is associated with poor prognosis in myeloid sarcoma patients. Hematological Oncology. 36(3). 591–599. 13 indexed citations

13.

Kawamoto, Keisuke, Hiroaki Miyoshi, Takaharu Suzuki, et al.. (2018). Cladribine treatment for Erdheim–Chester disease involving the central nervous system and concomitant polycythemia vera: A case report. Journal of Clinical and Experimental Hematopathology. 58(4). 161–165. 9 indexed citations

14.

Kawamoto, Keisuke, Hiroaki Miyoshi, Eriko Yanagida, et al.. (2017). Comparison of clinicopathological characteristics between T‐cell prolymphocytic leukemia and peripheral T‐cell lymphoma, not otherwise specified. European Journal Of Haematology. 98(5). 459–466. 9 indexed citations

15.

Kurita, Daisuke, Hiroaki Miyoshi, Ayako Ichikawa, et al.. (2017). Clinicopathological Study of Methotrexate-Associated Lymphoproliferative Disorders in Rheumatoid Arthritis Patients: Histological Classification and Predictive Factors for Disease Progression. Blood. 130. 4168–4168. 4 indexed citations

16.

Kawamoto, Keisuke, Hiroaki Miyoshi, Takaharu Suzuki, et al.. (2017). Frequent expression of CD30 in extranodal NK/T‐cell lymphoma: Potential therapeutic target for anti‐CD30 antibody‐based therapy. Hematological Oncology. 36(1). 166–173. 28 indexed citations

17.

Ichikawa, Ayako, Hiroaki Miyoshi, Takuji Yamauchi, et al.. (2017). Composite lymphoma of peripheral T‐cell lymphoma and Hodgkin lymphoma, mixed cellularity type; pathological and molecular analysis. Pathology International. 67(4). 194–201. 7 indexed citations

18.

Yokoyama, Shintaro, Hiroaki Miyoshi, Kazutaka Nakashima, et al.. (2016). Prognostic Value of Programmed Death Ligand 1 and Programmed Death 1 Expression in Thymic Carcinoma. Clinical Cancer Research. 22(18). 4727–4734. 68 indexed citations

19.

Suzuki, Yu, et al.. (2010). Cytological features of parathyroid carcinoma with anaplastic transformation. The Journal of the Japanese Society of Clinical Cytology. 49(5). 361–363.

20.

Miyoshi, Hiroaki, et al.. (1992). Spacecraft shielding verification at impact velocity over 10 km/sec. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact